GABRP Mediates GABA ‐A Receptor to Shape Tumor Immunosuppressive Microenvironment and Promote Tumor Immune Escape and Corresponding Targeted Therapy
Cancer Medicine · 2025
DOI: 10.1002/cam4.70946 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Wu Cen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Xingyi People's Hospital Affiliated to Guizhou Medical University, Xingyi, Guizhou Province, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Receptors, GABA-A, Tumor Escape, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The PhD Initiation Fund of Guizhou Medical University, China Guizhou Provincial Health Commission Science and Technology Fund Project, National Natural Science Foundation of Guizhou Medical University Affiliated Hospital.
Abstract (Originalsprache)
Background
Tumor immune evasion mediated by the immunosuppressive tumor microenvironment (TME) remains a major obstacle in cancer therapy. The γ‐aminobutyric acid receptor π subunit (GABRP) is aberrantly expressed in cancers, but its role in immune evasion is poorly defined.
Objective
To elucidate the mechanism of GABRP‐driven TME remodeling and evaluate its therapeutic potential. Materials and Methods Pan‐cancer bioinformatics analysis (TCGA, GEPIA2, cBioPortal) assessed GABRP expression, survival associations, and immune infiltration across 33 cancers. Functional studies included GABRP knockdown in glioma cells (U87/U251) via lentiviral RNAi, proliferation/migration assays (CCK‐8, scratch test), and pathway analysis. Subcutaneous xenografts in BALB/c‐nu mice evaluated the GABA_A inhibitor Amentoflavone. Immune profiling utilized ssGSEA and TIMER.
Results
GABRP was overexpressed in gliomas and other cancers (breast, gastric), correlating with poor prognosis (HR = 1.8, p = 0.008) and enriched immunosuppressive cells (Tregs, M2 macrophages). Knockdown suppressed proliferation (IC50↓42%), migration (> 50% delay, p < 0.01), and PI3K/AKT signaling. Amentoflavone reduced tumor volume by 68% ( p < 0.001) and reversed GABA‐mediated T cell inhibition.
Discussion
GABRP promotes immune evasion via GABA overproduction, recruiting Tregs/M2 macrophages to establish an immunosuppressive TME. Targeting GABRP or GABA signaling (e.g., Amentoflavone) restores antitumor immunity. Limitations include cohort size and tissue‐specific heterogeneity.
Conclusion
GABRP is a key regulator of tumor immunosuppression. Dual strategies—blocking GABRP expression or GABA signaling—offer novel therapeutic avenues. Clinical validation is needed to advance precision oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xingyi People's Hospital Affiliated to Guizhou Medical University, Xingyi, Guizhou Province, China.
- The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, China.
ORCID-Profile: Wu Cen, Liangzhao Chu
Förderung
- The PhD Initiation Fund of Guizhou Medical University
- China Guizhou Provincial Health Commission Science and Technology Fund Project
- National Natural Science Foundation of Guizhou Medical University Affiliated Hospital
- National Natural Science Foundation of China
Zitieren
APA
Cen, W., Fu, G., Wang, X., Wei, R., Zhou, X., Teng, W., Ling, Y., Tang, J., Wang, Z., & Chu, L. (2025). GABRP Mediates GABA ‐A Receptor to Shape Tumor Immunosuppressive Microenvironment and Promote Tumor Immune Escape and Corresponding Targeted Therapy. Cancer Medicine. https://doi.org/10.1002/cam4.70946
Vancouver
Cen W, Fu G, Wang X, Wei R, Zhou X, Teng W, et al. GABRP Mediates GABA ‐A Receptor to Shape Tumor Immunosuppressive Microenvironment and Promote Tumor Immune Escape and Corresponding Targeted Therapy. Cancer Medicine. 2025. doi:10.1002/cam4.70946
BibTeX
@article{Cen2025,
author = {Cen, Wu and Fu, Genyuan and Wang, Xiaoyu and Wei, Ruting and Zhou, Xingwang and Teng, Wei and Ling, Yuanguo and Tang, Jiaze and Wang, Zhongan and Chu, Liangzhao},
title = {GABRP Mediates GABA ‐A Receptor to Shape Tumor Immunosuppressive Microenvironment and Promote Tumor Immune Escape and Corresponding Targeted Therapy},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70946}
}
EUVIMED